Learn about the conditions and related clinical research and hear from other patients.
The study is to evaluate the efficacy and safety of evobrutinib administered orally twice ...
The study is to evaluate the efficacy and safety of evobrutinib administered orally twice ...
To assess safety and tolerability of patients converting from approved Relapsing Multiple ...
To determine the long-term (approximately 2 years) nephroprotective potential of treatment ...
English (USA)